Chin RFM, Neville BGR, Peckham C, Bedford H, Wade A, Scott RC. Incidence, cause, and short-term outcome of convulsive status epilepticus in childhood: prospective population-based study. Lancet. 2006;368(9531):222–9. https://doi.org/10.1016/S0140-6736(06)69043-0

Schnier C, Chin RF. Mortality in children with epilepsy: cohort study using the Clinical Practice Research Datalink. Seizure. 2023;109:77–82.

Article  PubMed  Google Scholar 

Trinka E, Cock H, Hesdorffer D, Rossetti AO, Scheffer IE, Shinnar S, et al. A definition and classification of status epilepticus: report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia. 2015;56(10):1515–23.

Article  PubMed  Google Scholar 

Meyer S, Langer J, Poryo M, Bay JG, Wagenpfeil S, Heinrich B, et al. Epileptic Status in a PEDiatric cohort (ESPED) requiring intensive care treatment: a multicenter, national, two-year prospective surveillance study. Epilepsia Open. 2023;8(2):411–24.

Article  PubMed  PubMed Central  Google Scholar 

Jindal M, Neligan A, Rajakulendran S. Early and established status epilepticus: the impact of timing of intervention, treatment escalation and dosing on outcome. Seizure. 2023;111:98–102.

Article  PubMed  Google Scholar 

Glauser T, Shinnar S, Gloss D, Alldredge B, Arya R, Bainbridge J, et al. Evidence-based guideline: treatment of convulsive status epilepticus in children and adults: report of the Guideline Committee of the American Epilepsy Society. Epilepsy Curr. 2016;16(1):48–61.

Article  PubMed  PubMed Central  Google Scholar 

Cheng JY. Latency to treatment of status epilepticus is associated with mortality and functional status. J Neurol Sci. 2016;370:290–5.

Article  PubMed  Google Scholar 

Chamberlain JM, Kapur J, Shinnar S, Elm J, Holsti M, Babcock L, et al. Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial. Lancet. 2020;395(10231):1217–24.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lyttle MD, Rainford NEA, Gamble C, Messahel S, Humphreys A, Hickey H, et al. Levetiracetam versus phenytoin for second-line treatment of paediatric convulsive status epilepticus (EcLiPSE): a multicentre, open-label, randomised trial. Lancet. 2019;393(10186):2125–34.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dalziel SR, Borland ML, Furyk J, Bonisch M, Neutze J, Donath S, et al. Levetiracetam versus phenytoin for second-line treatment of convulsive status epilepticus in children (ConSEPT): an open-label, multicentre, randomised controlled trial. Lancet. 2019;393(10186):2135–45.

Article  CAS  PubMed  Google Scholar 

Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivar Behav Res. 2011;46(3):399–424.

Article  Google Scholar 

Austin PC, Stuart EA. Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies. Stat Med. 2015;34(28):3661–79.

Article  PubMed  PubMed Central  Google Scholar 

Strzelczyk A, Brunklaus A, Rosenow F, Paprocka J, Schubert-Bast S, Kämppi L. Cost-of-illness review of status epilepticus in Europe. Epilepsy Behav. 2024;161: 110105.

Article  PubMed  Google Scholar 

Mitchell C, Chatterton Dickson L, Ramsay A, Mesalles-Naranjo O, Leonard P, Brand C, et al. Epidemiology and outcome of status epilepticus in children: a Scottish population cohort study. Dev Med Child Neuro. 2021;63(9):1075–84.

Article  Google Scholar 

Raspall-Chaure M, Chin RFM, Neville BG, Bedford H, Scott RC. The epidemiology of convulsive status epilepticus in children: a critical review: epidemiology of status epilepticus. Epilepsia. 2007;48(9):1652–63.

Article  PubMed  Google Scholar 

Vignesh V, Rameshkumar R, Mahadevan S. Comparison of phenytoin, valproate and levetiracetam in pediatric convulsive status epilepticus: a randomized double-blind controlled clinical trial. Indian Pediatr. 2020;57(3):222–7.

Article  PubMed  Google Scholar 

İşgüder R, Güzel O, Ceylan G, Yılmaz Ü, Ağın H. A Comparison of intravenous levetiracetam and valproate for the treatment of refractory status epilepticus in children. J Child Neurol. 2016;31(9):1120–6.

Article  PubMed  Google Scholar 

Noureen N, Khan S, Khursheed A, Iqbal I, Maryam M, Sharib SM, et al. Clinical efficacy and safety of injectable levetiracetam versus phenytoin as second-line therapy in the management of generalized convulsive status epilepticus in children: an open-label randomized controlled trial. J Clin Neurol. 2019;15(4):468.

Article  PubMed  PubMed Central  Google Scholar 

Nazir M, Tarray RA, Asimi R, Syed WA. Comparative efficacy of IV phenytoin, IV valproate, and IV levetiracetam in childhood status epilepticus. J Epilepsy Res. 2020;10(2):69–73.

Article  PubMed  PubMed Central  Google Scholar 

Besli GE, Yuksel Karatoprak E, Yilmaz S. Efficacy and safety profile of intravenous levetiracetam versus phenytoin in convulsive status epilepticus and acute repetitive seizures in children. Epilepsy Behav. 2020;111: 107289.

Article  PubMed  Google Scholar 

Köle MT, Sager SG, Zeynel H, Çağ Y, Akın Y. Efficacy of intravenous levetiracetam versus phenytoin in convulsive status epilepticus and acute repetitive seizures in children. Childs Nerv Syst. 2022;38(7):1357–64.

Article  PubMed  Google Scholar 

Handral A, Veerappa BG, Gowda VK, Shivappa SK, Benakappa N, Benakappa A. Levetiracetam versus fosphenytoin in pediatric convulsive status epilepticus: a randomized controlled trial. J Pediatr Neurosci. 2020;15(3):252–6.

Article  PubMed  PubMed Central  Google Scholar 

Wani G, Imran A, Dhawan N, Gupta A, Giri J. Levetiracetam versus phenytoin in children with status epilepticus. J Family Med Prim Care. 2019;8(10):3367.

Article  PubMed  PubMed Central  Google Scholar 

Nalisetty S, Kandasamy S, Sridharan B, Vijayakumar V, Sangaralingam T, Krishnamoorthi N. Clinical effectiveness of levetiracetam compared to fosphenytoin in the treatment of benzodiazepine refractory convulsive status epilepticus. Indian J Pediatr. 2020;87(7):512–9.

Article  PubMed  Google Scholar 

Singh K, Aggarwal A, Faridi M, Sharma S. IV Levetiracetam versus IV phenytoin in childhood seizures: a randomized controlled trial. J Pediatr Neurosci. 2018;13(2):158.

Article  PubMed  PubMed Central  Google Scholar 

Furyk JS, George S, Phillips N, Emeto TI, Watt K, O’Brien S, et al. Status Epilepticus Australasian Registry for Children: a pilot prospective, observational, cohort study of paediatric status epilepticus. Emerg Med Australas. 2022;34(5):801–7.

Article  PubMed  Google Scholar 

Sanford Kobayashi E, Waldman B, Engorn BM, Perofsky K, Allred E, Briggs B, et al. Cost efficacy of rapid whole genome sequencing in the pediatric intensive care unit. Front Pediatr. 2022;9: 809536.

Article  PubMed  PubMed Central  Google Scholar 

Kartal A. Can High-dose levetiracetam be safe? A case report of prolonged accidental high-dose levetiracetam administration and review of the literature. Clin Neuropharmacol. 2017;40(5):217.

Article  CAS  PubMed  Google Scholar 

Obeid M, Pong AW. Efficacy and tolerability of high oral doses of levetiracetam in children with epilepsy. Epilepsy Res. 2010;91(1):101–5.

Article  CAS  PubMed  Google Scholar 

Specchio N, Wirrell EC, Scheffer IE, Nabbout R, Riney K, Samia P, et al. International League Against Epilepsy classification and definition of epilepsy syndromes with onset in childhood: position paper by the ILAE Task Force on Nosology and Definitions. Epilepsia. 2022;63(6):1398–442.

Article  PubMed  Google Scholar